Built at the Internet Archive
Enter a search term on the right to search the text within the archived pages. Or for more search options, use the Advanced Search options below.
Sites for this collection are listed below. Narrow your results at left, or enter a search query below to find a site, specific URL or to search the text of archived webpages.
The following results were found for the term(s): pelvic mesh 2008
Page 1 of 8 (155 Total Results)Next Page ►
Sort By:
URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm479732.htm
This text was captured on Feb 08, 2019 Show All Captures
To warn doctors and patients about the use of surgical mesh for transvaginal POP repair, the FDA has: Issued safety communications in 2008 and in 2011 warning doctors and consumers about an increase in
Content: application/xhtml+xml Size: 44 KB
URL: https://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm262435.htm
This text was captured on Apr 06, 2017 Show All Captures
surgical mesh to repair pelvic organ prolapse and/or stress urinary incontinence Health care providers involved in the care of patients with surgical mesh implanted to repair pelvic organ prolapse and/
Content: application/xhtml+xml Size: 55 KB
URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm479732.htm
This text was captured on Jan 11, 2017 Show All Captures
To warn doctors and patients about the use of surgical mesh for transvaginal POP repair, the FDA has: Issued safety communications in 2008 and in 2011 warning doctors and consumers about an increase in
Content: application/xhtml+xml Size: 44 KB
This text was captured on Jan 25, 2018 Show All Captures
The FDA previously communicated about serious complications associated with transvaginal placement of surgical mesh to treat pelvic organ prolapse (POP) and SUI in the October 20, 2008 FDA Public Health
Content: application/xhtml+xml Size: 43 KB
This text was captured on Jan 11, 2017 Show All Captures
The FDA previously communicated about serious complications associated with transvaginal placement of surgical mesh to treat pelvic organ prolapse (POP) and SUI in the October 20, 2008 FDA Public Health
Content: application/xhtml+xml Size: 43 KB
This text was captured on Dec 25, 2020 Show All Captures
The FDA previously communicated about serious complications associated with transvaginal placement of surgical mesh to treat pelvic organ prolapse (POP) and SUI in the October 20, 2008 FDA Public Health
Content: text/html Size: 44 KB
URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm262752.htm
This text was captured on Jan 11, 2017 Show All Captures
The FDA issued a safety communication in 2008 due to increasing concerns about adverse events associated with the transvaginal placement of mesh .
Content: application/xhtml+xml Size: 38 KB
This text was captured on Jan 12, 2017 Show All Captures
[Posted 10/21/2008 ] FDA informed healthcare professionals of serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse (POP) and stress urinary incontinence
Content: application/xhtml+xml Size: 37 KB
URL: https://www.fda.gov/ScienceResearch/SpecialTopics/WomensHealthResearch/ucm522672.htm
This text was captured on Apr 06, 2017 Show All Captures
implantation in surgical interventions for the treatment of pelvic floor disorders, Phase III – Cara Krulewitch, CNM, PhD, CDRH (11) Evaluation of Safety and Effectiveness of Mesh Implantation in Surgical
Content: application/xhtml+xml Size: 53 KB
This text was captured on Dec 12, 2019 Show All Captures
implantation in surgical interventions for the treatment of pelvic floor disorders, Phase III – Cara Krulewitch, CNM, PhD, CDRH (11) Evaluation of Safety and Effectiveness of Mesh Implantation in Surgical
Content: text/html Size: 56 KB
URL: https://www.fda.gov/node/371329
This text was captured on Dec 12, 2019 Show All Captures
implantation in surgical interventions for the treatment of pelvic floor disorders, Phase III – Cara Krulewitch, CNM, PhD, CDRH (11) Evaluation of Safety and Effectiveness of Mesh Implantation in Surgical
Content: text/html Size: 56 KB
URL: https://www.fda.gov/media/81123/download
This text was captured on Dec 27, 2020 Show All Captures
Graft use in transvaginal pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 2008 ; 112(5): 1131-1142. 25.
Content: application/pdf Size: 252 KB
URL: https://www.fda.gov/downloads/MedicalDevices/Safety/AlertsandNotices/UCM262760.pdf
This text was captured on Apr 24, 2018 Show All Captures
Graft use in transvaginal pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 2008 ; 112(5): 1131-1142. 25.
Content: application/pdf Size: 252 KB
URL: https://www.fda.gov/media/122855/download
This text was captured on Dec 13, 2019 Show All Captures
Dolen, A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J Pelvic Floor Dysfunct, 2008 . 19(4): p. 467-71. 78.
Content: application/pdf Size: 209 KB
This text was captured on Feb 13, 2019 Show All Captures
Dolen, A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J Pelvic Floor Dysfunct, 2008 . 19(4): p. 467-71. 78.
Content: application/pdf Size: 209 KB
This text was captured on Apr 04, 2017 Show All Captures
Pelvic AND mesh AND morbidity (limit: Title) 27.
Content: application/pdf Size: 879 KB
This text was captured on Apr 24, 2019 Show All Captures
Am J Obstet Gynecol. 2008 Dec;199(6):688.e1-5. Epub 2008 Oct 31. 4. Brubaker L, et al.Am J Obstet Gynecol. 2014 Nov;211(5):554.e1-7.
Content: application/pdf Size: 139 KB
URL: https://www.fda.gov/media/122871/download
This text was captured on Dec 13, 2019 Show All Captures
Am J Obstet Gynecol. 2008 Dec;199(6):688.e1-5. Epub 2008 Oct 31. 4. Brubaker L, et al.Am J Obstet Gynecol. 2014 Nov;211(5):554.e1-7.
Content: application/pdf Size: 139 KB
URL: https://www.fda.gov/media/122854/download
This text was captured on Dec 13, 2019 Show All Captures
B. 2008 MAUDE Database Search and Public Health Notification From 2005 – 2008 , the FDA reviewed information regarding the safety of urogynecologic surgical mesh used to repair any type of POP or SUI.
Content: application/pdf Size: 911 KB
URL: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm395192.htm
This text was captured on Jan 12, 2017 Show All Captures
The FDA previously communicated about serious complications associated with transvaginal placement of surgical mesh to treat POP and stress urinary incontinence (SUI) in an Oct. 2008 FDA Public Health
Content: application/xhtml+xml Size: 37 KB
Page 1 of 8 (155 Total Results)Next Page ►
